PE20150359A1 - Manejo dietetico de la enfermedad celiaca y alergia alimentaria - Google Patents

Manejo dietetico de la enfermedad celiaca y alergia alimentaria

Info

Publication number
PE20150359A1
PE20150359A1 PE2014002500A PE2014002500A PE20150359A1 PE 20150359 A1 PE20150359 A1 PE 20150359A1 PE 2014002500 A PE2014002500 A PE 2014002500A PE 2014002500 A PE2014002500 A PE 2014002500A PE 20150359 A1 PE20150359 A1 PE 20150359A1
Authority
PE
Peru
Prior art keywords
component
celiac disease
food allergy
dietary management
lgg
Prior art date
Application number
PE2014002500A
Other languages
English (en)
Inventor
Gretchen Tanbonliong
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20150359A1 publication Critical patent/PE20150359A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion proporciona composiciones y metodos para el manejo dietetico de la enfermedad celiaca y alergia alimentaria en un sujeto, como un bebe alimentado con formula mediante administracion enteral de una cantidad efectiva de al menos una proteina hidrolizada y el Lactobacillus rhamnosus GG (LGG). Las composiciones nutricionales inventivas pueden contener un componente de proteina hidrolizada, un componente de lipido, un componente de carbohidrato, un componente de vitamina, un componente de mineral y un componente prebiotico ademas de un componente probiotico, el cual comprende una cantidad efectiva de LGG
PE2014002500A 2012-06-20 2013-05-22 Manejo dietetico de la enfermedad celiaca y alergia alimentaria PE20150359A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/528,818 US20130344042A1 (en) 2012-06-20 2012-06-20 Dietary management of celiac disease and food allergy

Publications (1)

Publication Number Publication Date
PE20150359A1 true PE20150359A1 (es) 2015-04-06

Family

ID=48537029

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2014002500A PE20150359A1 (es) 2012-06-20 2013-05-22 Manejo dietetico de la enfermedad celiaca y alergia alimentaria

Country Status (20)

Country Link
US (1) US20130344042A1 (es)
EP (1) EP2863761B1 (es)
CN (2) CN112237280A (es)
AR (1) AR094624A1 (es)
AU (1) AU2013277652B2 (es)
BR (1) BR112014027820A2 (es)
CA (1) CA2877308C (es)
EC (1) ECSP15001892A (es)
ES (1) ES2682285T3 (es)
HK (1) HK1207798A1 (es)
MX (1) MX356300B (es)
MY (1) MY169755A (es)
NZ (1) NZ701398A (es)
PE (1) PE20150359A1 (es)
PH (1) PH12014502811A1 (es)
PL (1) PL2863761T3 (es)
RU (1) RU2014150662A (es)
SG (1) SG11201407038XA (es)
TW (1) TWI639438B (es)
WO (1) WO2013191845A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014021388A2 (pt) 2012-02-29 2017-07-18 Ethicon Endo Surgery Inc composições de microbiota e métodos rela-cionados às mesmas
EP3082842B1 (en) * 2013-12-16 2022-04-13 Société des Produits Nestlé S.A. Newly identified peptides for use in the induction of oral tolerance
FR3020949B1 (fr) * 2014-05-16 2018-02-09 Ecole Normale Superieure De Lyon Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition
FI127483B (en) * 2014-06-11 2018-07-13 Gut Guide Oy Microbial marker for celiac disease and related product
US20160095339A1 (en) * 2014-10-01 2016-04-07 Mead Johnson Nutrition Company Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
CN108064132A (zh) 2014-10-31 2018-05-22 霍勒拜欧姆公司 与病症的微生物治疗和诊断有关的方法和组合物
CN106520603B (zh) * 2016-10-27 2020-01-21 江南大学 一种在细胞水平筛选具有增强肠道细胞紧密连接功能益生菌的方法
CA3066620A1 (en) * 2017-06-08 2018-12-13 Allergyintellect, Inc Vitamin d compounds and methods of using the same
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
US11392854B2 (en) 2019-04-29 2022-07-19 Kpn Innovations, Llc. Systems and methods for implementing generated alimentary instruction sets based on vibrant constitutional guidance

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
ES2746173T3 (es) * 2003-09-23 2020-03-05 Dsm Ip Assets Bv Uso de endoproteasas específicas para prolina para hidrolizar péptidos y proteínas
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
US20100028449A1 (en) * 2006-06-06 2010-02-04 Satya Prakash Fermented milk product and use thereof
ATE510460T1 (de) * 2007-05-18 2011-06-15 Mead Johnson Nutrition Co Gesäuertes flüssiges muttermilch-ergänzungsmittel
US8652508B2 (en) * 2007-05-25 2014-02-18 Children's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
EP2293802A4 (en) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc LACTOSE COMPOSITIONS HAVING REDUCED LACTOSE CONTENT
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
US10576110B2 (en) * 2009-05-11 2020-03-03 Societe Des Produits Nestle S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization

Also Published As

Publication number Publication date
EP2863761B1 (en) 2018-06-27
PH12014502811B1 (en) 2015-03-02
CN112237280A (zh) 2021-01-19
AU2013277652B2 (en) 2016-07-21
RU2014150662A (ru) 2016-08-10
SG11201407038XA (en) 2014-11-27
TWI639438B (zh) 2018-11-01
BR112014027820A2 (pt) 2017-06-27
CA2877308A1 (en) 2013-12-27
TW201410251A (zh) 2014-03-16
PL2863761T3 (pl) 2019-03-29
ECSP15001892A (es) 2015-09-30
PH12014502811A1 (en) 2015-03-02
NZ701398A (en) 2016-10-28
ES2682285T3 (es) 2018-09-19
MY169755A (en) 2019-05-15
EP2863761A1 (en) 2015-04-29
WO2013191845A1 (en) 2013-12-27
AU2013277652A1 (en) 2014-11-13
HK1207798A1 (en) 2016-02-12
AR094624A1 (es) 2015-08-19
CA2877308C (en) 2020-04-14
MX356300B (es) 2018-05-23
CN104394714A (zh) 2015-03-04
US20130344042A1 (en) 2013-12-26
MX2014013845A (es) 2015-02-12

Similar Documents

Publication Publication Date Title
PE20150359A1 (es) Manejo dietetico de la enfermedad celiaca y alergia alimentaria
BR112015023484A2 (pt) composição de carboidrato, produto e processso para preparar uma composição de carboidrato
BR112014016251A2 (pt) composições e métodos para modificação da flora gastrointestinal
BR112015015870A2 (pt) composição farmacêutica
BR112015024040A2 (pt) preparação alergênica
MX2016014509A (es) Formulacion de vitamina soluble en grasa.
BR112017026241A2 (pt) composições farmacêuticas e alimentícias para induzir a saciação e prolongar a saciedade em indivíduos que necessitem das mesmas
BR112014017469A8 (pt) produto de confeitaria congelado de baixa proteína
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
MX2022011742A (es) Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados.
BR112018011476A2 (pt) formulação de vitamina
BR112015011759A2 (pt) composição simbiótica e uso da mesma
MA40645A (fr) Préparation prébiotique à base d'inuline
AR096942A1 (es) Métodos para promocionar el desarrollo neuronal y/o la salud
PH12015502242B1 (en) Lutein composition suitable for infant food formulations
BR112017019364A2 (pt) dispersões sólidas
PE20141022A1 (es) Composiciones y procedimientos para la administracion de nutrientes
BR112014000599A2 (pt) sistema dietético multicomponentes
CO7151510A2 (es) Manejo dietético de la enfermedad cilíaca y la alergia a los alimentos
BR112018000521A2 (pt) composições alimentares para prevenir e tratar doenças inflamatórias
MX2012006534A (es) Composicion de fructo-oligosacaridos e inulina de agave de alta pureza con un probiotico y sus usos.
WO2013029634A3 (es) Composición antioxidante, antigripal natural
MX2016017184A (es) Proceso de obtencion de laminas de fruta suplementadas con prebioticos de plantas del genero agave.
BR112018005447A2 (pt) métodos para aprimorar a tolerância gastrointestinal a produtos alimentícios e bebidas que compreendem carboidratos doces de baixa digestibilidade
PL401895A1 (pl) Zastosowanie preparatu fosfolipidowego z zóltka jaj

Legal Events

Date Code Title Description
FD Application declared void or lapsed